Retraction
RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
Paper Information
Record ID:
24178
Author(s):
Journal:
Publication Date:
August 26, 2005
Retraction Date:
September 11, 2020
(5.2 years years ago)
Subjects:
Institutions:
- Department of Biomedical and Therapeutic Sciences (Program of Cancer Biology), University of Illinois College of Medicine, Peoria, Illinois 61656
- Department of Surgery,University of Illinois College of Medicine, Peoria, Illinois 61656
- Department of Pathology, University of Illinois College of Medicine, Peoria, Illinois 61656
- Department of Neurosurgery, University of Illinois College of Medicine, Peoria, Illinois 61656
Country:
🇺🇸 United StatesArticle Type:
Publisher:
American Society for Biochemistry and Molecular Biology (ASBMB)
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1074/jbc.RX120.015588Additional Notes:
Jasti S Rao has institutional finding of misconduct;
Citations (296)
296
Total Citations35
Post-Retraction(11.8%)
258
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
8
Within 1 year
23
After 2+ years
1554
Days since retraction (latest)
Paper citing RNA interference-directed knockdown of urokinase p...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Expression of antisense uPAR and antisense uPA fro...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Expression of antisense uPAR and antisense uPA fro...
Unknown Authors
Unknown Journal
Published: Unknown
Immunotherapy for Prostate Cancer
Atefeh Bijanvand, Sheyda Khalilian, Amir Hossein Loghman et al. (4 authors)
Unknown Journal
Published: Dec 2024
1554 days after retraction
Apoptotic Potential of Iloneoside from Gongronema latifolium Benth against Prostate Cancer Cells Using In Vitro and In Silico Approach
Gideon Ampoma Gyebi, Saheed O. Afolabi, Oludare M. Ogunyemi et al. (7 authors)
Cell Biochemistry and Biophysics
Open Access
Published: Sep 2024
1 citation
1 citation
1470 days after retraction
CD87-targeted BiTE and CAR-T cells potently inhibit invasive nonfunctional pituitary adenomas
Yuan Ren, Xinjie Bao, Ming Feng et al. (7 authors)
Science China Life Sciences
Published: Jul 2024
1396 days after retraction
Paper citing RNA interference-directed knockdown of urokinase p...
Unknown Authors
Unknown Journal
Published: May 2024
1329 days after retraction
Potential anti-cancer properties of malvidin and its glycosides: Evidence from in vitro and in vivo studies
Rachit Sood, Sanjay Sanjay, Hyo‐Kyoung Choi et al. (4 authors)
Journal of Functional Foods
Open Access
Published: Apr 2024
5 citations
5 citations
1321 days after retraction
Disable 2, A Versatile Tissue Matrix Multifunctional Scaffold Protein with Multifaceted Signaling: Unveiling Role in Breast Cancer for Therapeutic Revolution
Nidhi N. Shah, Bhavarth P. Dave, Kashvi C. Shah et al. (6 authors)
Cell Biochemistry and Biophysics
Published: Apr 2024
1 citation
1 citation
1306 days after retraction
Development of a System for Fast Identification and Characterization of Biological Cells
Viviane S. Teixeira
Unknown Journal
Open Access
Published: Jan 2024
1228 days after retraction
An Update on Recent Treatment Approaches for Prostate Cancer
Atefeh Bijanvand, Sheyda Khalilian, Amir Hossein Loghman et al. (4 authors)
Springer eBooks
Published: Jan 2024
1207 days after retraction
Efficient Green Synthesis, Anticancer Activity, and Molecular Docking Studies of Indolemethanes Using a Bioglycerol-Based Carbon Sulfonic Acid Catalyst
Sailam Sri Gogula, Dasari Vijaya Prasanna, Vishnu Thumma et al. (8 authors)
ACS Omega
Open Access
Published: Sep 2023
9 citations
9 citations
1104 days after retraction
Avaliação da expressão dos principais complexos de manutenção telomérica na progressão do câncer de próstata
Gabriel Arantes Galvão Dias dos Santos
Unknown Journal
Open Access
Published: May 2023
987 days after retraction
Reports of Plant-Derived Nanoparticles for Prostate Cancer Therapy
Abdulrahman M. Elbagory, Rodney Hull, Mervin Meyer et al. (4 authors)
Plants
Open Access
Published: May 2023
6 citations
6 citations
964 days after retraction
Data from Targeted Knockdown of <i>Notch1</i> Inhibits Invasion of Human Prostate Cancer Cells Concomitant with Inhibition of Matrix Metalloproteinase-9 and Urokinase Plasminogen Activator
Bilal Bin Hafeez, Vaqar M. Adhami, Mohammad Asim et al. (10 authors)
Unknown Journal
Open Access
Published: Mar 2023
931 days after retraction
Data from Urokinase Plasminogen Activator Receptor and/or Matrix Metalloproteinase-9 Inhibition Induces Apoptosis Signaling through Lipid Rafts in Glioblastoma Xenograft Cells
Chandramu Chetty, Sajani S. Lakka, Praveen Bhoopathi et al. (10 authors)
Unknown Journal
Open Access
Published: Mar 2023
931 days after retraction
Data from Urokinase Plasminogen Activator Receptor and/or Matrix Metalloproteinase-9 Inhibition Induces Apoptosis Signaling through Lipid Rafts in Glioblastoma Xenograft Cells
Chandramu Chetty, Sajani S. Lakka, Praveen Bhoopathi et al. (10 authors)
Unknown Journal
Open Access
Published: Mar 2023
931 days after retraction
Supplementary Methods and Figure Legends 1-3 and Table 1 from Demethylation-Linked Activation of Urokinase Plasminogen Activator Is Involved in Progression of Prostate Cancer
Sai Murali Krishna Pulukuri, Norman Estes, Jitendra Patel et al. (4 authors)
Unknown Journal
Open Access
Published: Mar 2023
930 days after retraction
Supplementary Methods and Figure Legends 1-3 and Table 1 from Demethylation-Linked Activation of Urokinase Plasminogen Activator Is Involved in Progression of Prostate Cancer
Sai Murali Krishna Pulukuri, Norman Estes, Jitendra Patel et al. (4 authors)
Unknown Journal
Open Access
Published: Mar 2023
930 days after retraction
Data from Small Interfering RNA–Directed Reversal of Urokinase Plasminogen Activator Demethylation Inhibits Prostate Tumor Growth and Metastasis
Sai Murali Krishna Pulukuri, Jasti S. Rao
Unknown Journal
Open Access
Published: Mar 2023
930 days after retraction
Data from Small Interfering RNA–Directed Reversal of Urokinase Plasminogen Activator Demethylation Inhibits Prostate Tumor Growth and Metastasis
Sai Murali Krishna Pulukuri, Jasti S. Rao
Unknown Journal
Open Access
Published: Mar 2023
930 days after retraction
Anti-cancer potential of synergistic phytochemical combinations is influenced by the genetic profile of prostate cancer cell lines
Carol A. Gano, Shadma Fatima, Timothy W. Failes et al. (12 authors)
Frontiers in Nutrition
Open Access
Published: Mar 2023
9 citations
9 citations
907 days after retraction
Paper citing RNA interference-directed knockdown of urokinase p...
Unknown Authors
Unknown Journal
Published: Jan 2023
842 days after retraction
Anticancer Effects of Propolis Extracts Obtained with the Cold Separation Method on PC-3 and DU-145 Prostate Cancer Cell Lines
Marek Gogacz, Jerzy Peszke, Dorota Natorska‐Chomicka et al. (5 authors)
Molecules
Open Access
Published: Nov 2022
7 citations
7 citations
806 days after retraction
Chemical Profiling, Antiproliferative and Antimigratory Capacity of Haberlea rhodopensis Extracts in an In Vitro Platform of Various Human Cancer Cell Lines
Katerina Spyridopoulou, Sotiris Kyriakou, Angeliki Nomikou et al. (11 authors)
Antioxidants
Open Access
Published: Nov 2022
8 citations
8 citations
802 days after retraction
Suppression Effects of Excessively Expressed Gene BCL-2 in Cell Lines of Prostate Cancer
Igor Esmerov, Branko Atanasov, Aleksandra Angelevska et al. (9 authors)
Macedonian Veterinary Review
Open Access
Published: Oct 2022
750 days after retraction
Epigenetic-Like Stimulation of Receptor Expression in SSTR2 Transfected HEK293 Cells as a New Therapeutic Strategy
Joerg Kotzerke, Dorothee Buesser, Anne Naumann et al. (8 authors)
Cancers
Open Access
Published: May 2022
13 citations
13 citations
615 days after retraction
ADAMTS-3’ ün (A Disintegrin and Matrix Metalloproteinase Type,1 Motif 3) Normal ve Kanserli Hücre Hatlarındaki Ekspresyon Paterni
Meltem Alper, Ayşe Tuğşen AYDEMİR, Feray Köçkar
Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi
Open Access
Published: Mar 2022
561 days after retraction
8-Geranyloxycarbostyril as a potent 15-LOX-1 inhibitor showed great anti-tumor effects against prostate cancer
Mehrdad Aghasizadeh, Tayebe Moghaddam, Ahmad Reza Bahrami et al. (6 authors)
Life Sciences
Published: Jan 2022
14 citations
14 citations
495 days after retraction
Theranostic applications of metal–organic frameworks (MOFs)-based materials in brain disorders: Recent advances and challenges
Mehdi Bazi Alahri, Razieh Arshadizadeh, Mohammadali Raeisi et al. (8 authors)
Inorganic Chemistry Communications
Published: Oct 2021
38 citations
38 citations
397 days after retraction
Plasminogen Activator Urokinase Receptor Implies Immunosuppressive Features and Acts as an Unfavorable Prognostic Biomarker in Glioma
Fan Zeng, Guanzhang Li, Xiu Liu et al. (7 authors)
The Oncologist
Open Access
Published: Mar 2021
30 citations
30 citations
179 days after retraction
The Prognostic Value and Mechanisms of TMEM16A in Human Cancer
Wenjian Chen, Meng Gu, Chaobing Gao et al. (9 authors)
Frontiers in Molecular Biosciences
Open Access
Published: Feb 2021
14 citations
14 citations
160 days after retraction
Faculty Opinions recommendation of IL-6 produced by prostate epithelial cells stimulated with Trichomonas vaginalis promotes proliferation of prostate cancer cells by inducing M2 polarization of THP-1-derived macrophages.
David Leitsch
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
Open Access
Published: Feb 2021
153 days after retraction
Identifying metastatic ability of prostate cancer cell lines using native fluorescence spectroscopy and machine learning methods
Jianpeng Xue, Yang Pu, Jason T. Smith et al. (6 authors)
Scientific Reports
Open Access
Published: Jan 2021
17 citations
17 citations
137 days after retraction
Targeting therapy for prostate cancer by pharmaceutical and clinical pharmaceutical strategies
Wanxiao Sun, Yaxin Deng, Meihui Zhao et al. (10 authors)
Journal of Controlled Release
Published: Jan 2021
30 citations
30 citations
124 days after retraction
Study on the pathophysiological mechanism responsible for lower urinary tract symptoms associated with prostate cancer using an animal model
Lin‐Nei Hsu, Yuh‐Shyan Tsai, Hsin‐Tzu Tsai et al. (5 authors)
LUTS Lower Urinary Tract Symptoms
Published: Jan 2021
1 citation
1 citation
117 days after retraction
New Pieces in the Puzzle of uPAR Role in Cell Migration Mechanisms
Anna Gorrasi, Anna Maria Petrone, Anna Li Santi et al. (6 authors)
Cells
Open Access
Published: Nov 2020
12 citations
12 citations
74 days after retraction
Genetic analysis of the molecular regulation of electric fields-guided glia migration
Li Yao, Teresa D. Shippy, Yongchao Li
Scientific Reports
Open Access
Published: Oct 2020
4 citations
4 citations
27 days after retraction
QSAR, QSTR, and molecular docking studies of the anti-proliferative activity of phenylpiperazine derivatives against DU145 prostate cancer cell lines
Fabian A. Ikwu, Gideon Adamu Shallangwa, Paul Andrew Mamza
Beni-Suef University Journal of Basic and Applied Sciences
Open Access
Published: Jul 2020
16 citations
16 citations
44 days before retraction
Protein-coated corrole nanoparticles for the treatment of prostate cancer cells
Matan Soll, Qiu‐Cheng Chen, Benny Zhitomirsky et al. (8 authors)
Cell Death Discovery
Open Access
Published: Jul 2020
21 citations
21 citations
45 days before retraction
Discovery of Novel Non-Steroidal Cytochrome P450 17A1 Inhibitors as Potential Prostate Cancer Agents
Tomasz M. Wróbel, Oksana Rogova, Kasper Langebjerg Andersen et al. (9 authors)
International Journal of Molecular Sciences
Open Access
Published: Jul 2020
10 citations
10 citations
64 days before retraction
Prostate cancer-derived holoclones: a novel and effective model for evaluating cancer stemness
Louise Flynn, Martin P. Barr, Anne‐Marie Baird et al. (13 authors)
Scientific Reports
Open Access
Published: Jul 2020
13 citations
13 citations
64 days before retraction
Ab locks for improving the selectivity and safety of antibody drugs
Wen-Wei Lin, Yun‐Chi Lu, Chih-Hung Chuang et al. (4 authors)
Journal of Biomedical Science
Open Access
Published: Jun 2020
30 citations
30 citations
78 days before retraction
Cabazitaxel exhibits more favorable molecular changes compared to other taxanes in androgen‐independent prostate cancer cells
Özge Çevik, Hilal Acıdereli, Fatma Aysun Turut et al. (5 authors)
Journal of Biochemical and Molecular Toxicology
Published: Jun 2020
24 citations
24 citations
79 days before retraction
Gallic acid, a phenolic acid, hinders the progression of prostate cancer by inhibition of histone deacetylase 1 and 2 expression
Yin-Gi Jang, Eul‐Bee Ko, Kyung‐Chul Choi
The Journal of Nutritional Biochemistry
Published: Jun 2020
54 citations
54 citations
101 days before retraction
MicroRNA‑137 regulates hypoxia‑mediated migration and epithelial‑mesenchymal transition in prostate cancer by targeting LGR4 via the EGFR/ERK signaling pathway
Hao Zhang, Fang Liang, Junmin Yue et al. (11 authors)
International Journal of Oncology
Open Access
Published: May 2020
19 citations
19 citations
120 days before retraction
Tubulin-Binding 3,5-Bis(styryl)pyrazoles as Lead Compounds for the Treatment of Castration-Resistant Prostate Cancer
Vivian W. Y. Liao, Anuradha Kumari, Rajeshwar Narlawar et al. (7 authors)
Molecular Pharmacology
Open Access
Published: Apr 2020
11 citations
11 citations
162 days before retraction
IL-6 produced by prostate epithelial cells stimulated with Trichomonas vaginalis promotes proliferation of prostate cancer cells by inducing M2 polarization of THP-1-derived macrophages
Ik‐Hwan Han, Hyun-Ouk Song, Jae‐Sook Ryu
PLoS neglected tropical diseases
Open Access
Published: Mar 2020
71 citations
71 citations
175 days before retraction
In Vitro Vascular Network Modified to Function as Culture Platform and Angiogenic Induction Potential Test for Cancer Cells
Outi Huttala, Synnöve Staff, Tuula Heinonen et al. (6 authors)
International Journal of Molecular Sciences
Open Access
Published: Mar 2020
2 citations
2 citations
189 days before retraction
Improved therapeutic efficacy of quercetin-loaded polymeric nanoparticles on triple-negative breast cancer by inhibiting uPA
Yang Zhou, Dan Chen, Guangpu Xue et al. (7 authors)
RSC Advances
Open Access
Published: Jan 2020
32 citations
32 citations
254 days before retraction
Quick Stats
Total Citations:
296
Years Since Retraction:
5.2 years
Open Access:
Yes
Last Checked:
Jul 24, 2025